Ensoma
Latest round
- Series B
Last raised
- Sep 2025
Total raised
- $215M
Investors
- 21
About Ensoma
Ensoma, Inc.Founded in 2019 and headquartered in Boston, US, Ensoma specializes in advanced biotechnology solutions.Ensoma specializes in advanced in vivo hematopoietic stem cell (HSC) engineering technology. The company's core offerings center around a comprehensive platform that integrates an off-the-shelf delivery system with a sophisticated gene engineering toolkit. This platform enables the precise and durable modification of cells within the entire hematopoietic system, targeting various diseases through a one-time therapy approach. Ensoma's innovative treatments aim to address genetic, immune, and oncological diseases, significantly enhancing the patient experience by providing simple, fast, and safe solutions.Ensoma's revenue model is centered around partnerships and collaborations with healthcare providers, research institutions, and pharmaceutical companies. The company engages in direct transactions with clients who seek its innovative HSC engineering solutions for therapeutic applications. These arrangements may involve licensing agreements or joint development partnerships, allowing for tailored solutions that meet specific client needs. The flagship offerings, facilitated through this model, include proprietary gene editing technologies that are delivered as comprehensive treatment solutions.In May 2023, Ensoma, Inc. Ensoma is also looking to expand its operations into new geographic markets, including Europe and Asia, by the end of 2024, aiming to increase accessibility to its innovative treatments. In September 2025, Ensoma, Inc.
Who invested in Ensoma
21 investors across 5 rounds
See all investors in Ensoma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Ensoma
Who invested in Ensoma?
Ensoma has 21 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Ensoma raised?
Ensoma has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Ensoma last raise money?
Ensoma's most recent round on record is a Series B, in Sep 2025.
What does Ensoma do?
Ensoma is a biotechnology company.
Where is Ensoma headquartered?
Ensoma is headquartered in Boston, US.
Which VCs invest in companies like Ensoma?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Ensoma's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Ensoma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.